Ceftazidime and Sulfamethoxazole drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Ceftazidime (ceftazidime) and Sulfamethoxazole (sulfamethoxazole). Common drug interactions include adhesion among females and pyrexia among males.

The phase IV clinical study analyzes what interactions people have when they take Ceftazidime and Sulfamethoxazole. It is created by eHealthMe based on reports of 64 people who take the same drugs from the FDA, and is updated regularly.

What is Ceftazidime?

Ceftazidime has active ingredients of ceftazidime. eHealthMe is studying from 10,327 Ceftazidime users. Check the latest studies of Ceftazidime.

What is Sulfamethoxazole?

Sulfamethoxazole has active ingredients of sulfamethoxazole. It is often used in urinary tract infection. eHealthMe is studying from 13,360 Sulfamethoxazole users. Check the latest studies of Sulfamethoxazole.

On Jul, 12, 2026

64 people who take Ceftazidime and Sulfamethoxazole together, and have interactions are studied.

Ceftazidime and Sulfamethoxazole drug interactions.

What are the common drug interactions of Ceftazidime and Sulfamethoxazole, by gender? *:

female:

Adhesion
Anaemia (lack of blood)
Blood urea increased
Conjunctivitis (pink eye)
Dental caries
Overweight
Tooth disorder (tooth disease)
Tooth extraction
Upper respiratory tract infection
Acute sinusitis

male:

Pyrexia (fever)
Diarrhoea
Chest pain
Hypoxia (low oxygen in tissues)
Nausea (feeling of having an urge to vomit)
Swelling face
Abdominal pain
Actinomycosis (infection that causes sores, or abscesses)
Adjustment disorder
Adrenal insufficiency (a condition in which the adrenal glands do not produce adequate amounts of steroids)

What are the common drug interactions of Ceftazidime and Sulfamethoxazole, by age (0-1 to 60+)? *:

0-1:

Acute lymphocytic leukaemia (cancer of the white blood cells)
Chest pain
Limb injury
Lung infiltration (a substance that normally includes fluid, inflammatory exudates or cells that fill a region of lung)
Molluscum contagiosum (a viral infection of the skin or occasionally of the mucous membranes)
Petechiae (a small red or purple spot caused by bleeding into the skin)
Pyrexia (fever)
Diarrhoea
Dyshidrosis (skin condition in which blisters develop on the soles of your feet and/or the palms of hands)
Dyspnoea (difficult or laboured respiration)

2-9:

Adhesion
Conjunctivitis (pink eye)
Dental caries
Overweight
Pyrexia (fever)
Tooth disorder (tooth disease)
Tooth extraction
Upper respiratory tract infection
Acute sinusitis
Anaemia (lack of blood)

10-19:

Cardiac failure
Arrhythmia (irregular heartbeat)
Febrile neutropenia (fever with reduced white blood cells)
Graft versus host disease (the donated bone marrow or stem cells view the recipient's body as foreign, and the donated cells/bone marrow attack the body)
Hepatic vein occlusion (blockage of the hepatic vein)
Hyperglycaemia (high blood sugar)
Oedema (fluid collection in tissue)
Adverse reaction
Altered state of consciousness (altered state of mind)
Bacteraemia (presence of bacteria in the blood)

20-29:

Haemoptysis (blood-stained sputum from the bronchi, larynx, trachea, or lungs)
Pulmonary haemorrhage (acute bleeding from the lung)
Sepsis (a severe blood infection that can lead to organ failure and death)

30-39:

Blood urea increased
Angina unstable (chest pain due to ischemia of the heart muscle- unstable)
Blood glucose increased
Chest pain
Haemoglobin decreased
Lymphocyte count decreased
Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)
Neutrophil count increased (excess than normal number of neutrophil a type of blood cell)
Platelet count decreased
White blood cell count decreased

40-49:

Blood pressure increased
Engraft failure
Pyrexia (fever)
Rash
Stenotrophomonas infection
Chronic kidney disease
Cytokine release syndrome (immediate complication occurring with the use of anti-t cell antibody infusions)
Escherichia sepsis (bacterial infection by escherichia coli)
Therapeutic response decreased (less preventive response)
Tooth infection

50-59:

Pyrexia (fever)
Antiphospholipid syndrome (disorder that manifests clinically as recurrent venous or arterial thrombosis and/or fetal loss)
Body temperature increased
Drug ineffective
General physical health deterioration (weak health status)
Inflammatory marker increased
Klebsiella infection
Lower respiratory tract infection bacterial
Lung disorder (lung disease)
Pathogen resistance

60+:

Bacteraemia (presence of bacteria in the blood)
Endocarditis (inflammation in heart muscle)
Respiratory failure (inadequate gas exchange by the respiratory system)
Splenic abscess (pus in spleen or near by)
Splenic infarction (tissue damage of spleen)
Chills (felling of cold)
Interstitial lung disease
Thrombocytopenia (decrease of platelets in blood)
Anaemia (lack of blood)
Cardiac valve disease (heart valve disease)

What are the existing conditions these people have? *

Rashes (redness): 10 people, 15.62%
Dermatitis (inflammation of the skin resulting from direct irritation by an external agent or an allergic reaction to it): 7 people, 10.94%
Neutrophil Count Decreased (less than normal number of neutrophil a type of blood cell): 5 people, 7.81%
Infection: 4 people, 6.25%
Immunodeficiency Disorders: 4 people, 6.25%
Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 4 people, 6.25%
High Blood Pressure: 4 people, 6.25%
Bacteraemia (presence of bacteria in the blood): 4 people, 6.25%
Anaemia (lack of blood): 4 people, 6.25%

* Approximation only. Some reports may have incomplete information.

Do you take Ceftazidime and Sulfamethoxazole?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously